These data suggest that while reductions in mycobacterial burden through TB treatment may not necessarily increase the frequency of polyfunctional PPD-specific CD4 T-cells, it does alter the functional profile of PPD-specific CD4 T-cells, specifically with respect to IL-2 and MIP-1β producing subsets. The gene discussed is IL2; the disease is tuberculosis.